Verve Therapeutics
VERV
#6795
Rank
NZ$0.86 B
Marketcap
$10.16
Share price
11.24%
Change (1 day)
-55.24%
Change (1 year)

Earnings for Verve Therapeutics (VERV)

Earnings in 2024 (TTM): -NZ$0.37 Billion

According to Verve Therapeutics's latest financial reports the company's current earnings are NZ$24.39 Million. In 2023 the company made an earning of -NZ$0.4 Billion a decrease over its 2022 earnings that were of -NZ$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verve Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.37 Billion-7.14%
2023 -NZ$0.4 Billion34.67%
2022 -NZ$0.3 Billion90.3%
2021 -NZ$0.16 Billion114.31%
2020 -NZ$71.92 Million